FundingPayments

Correlia Biosystems: Raises $7M in Series A Funding

  • Correlia Biosystems, a Berkeley, CA-based life science startup, closed a $7m Series A financing round
  • The round led by Neotribe Ventures, joined by Cota Capital, the Regents of the University of California, and others
  • NeoTribe Ventures joins Correlia’s board of directors as part of the financing
  • The company also intends to use the funds for the commercial launch of its immunoassay platform
  • This will also the first instrument planned in their larger suite of proteomics tools focused on highly efficient and automated protein measurements
  • Correlia is launching a product to miniaturize Elisa, a quantitative test for proteins and antibodies widely used in drug development, vaccine development, and diagnostics
Previous article
Shinhan Bank: Enhanced Cooperations with partners in diversified fields
Next article
Alliance Data: Completes Acquisition of Bread
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

NatWest Strengthens Venture Banking by Partnering with AWS

Collaboration will enhance digital services for startups and scale-ups.Highlights: NatWest partners with AWS to launch a new venture...
FinTech

UK Authorities Tighten Regulations on P2P Crypto Trading

New measures aim to enhance security for crypto traders in the peer-to-peer market.Highlights: UK authorities introduce new regulations...
FinTech

Citi Wealth Strengthens Services with New AI-Powered Team Member

Citi Wealth Management introduces advanced AI technology for enhanced client experience.Highlights: Citi Wealth Management has launched a new...
FinTech

Coinbase Lists First GBP Stablecoin, Expanding Market Options

The new stablecoin aims to enhance trading in the UK market.Highlights: Coinbase has launched the first GBP stablecoin.This...